Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1993-11-15
1995-09-05
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424423, 424424, 424425, 424450, 427 212, 5147722, 514822, 523112, 523113, 604 53, 604266, 623 12, A61F 204, A01N 102, A61M 532
Patent
active
054477247
ABSTRACT:
A medical device and a method for its manufacture. The function of the medical device requires exposure of the device to the tissue of a patient. The device has a tissue-exposed portion constructed to release an agent that inhibits adverse reaction to the presence of the device defined by a polymeric surface-layer overlying in a supported manner a polymer defining a reservoir. The reservoir incorporates the agent in a manner that permits substantially free outward release of the agent from the reservoir and the overlying layer defines metering outward passages constructed to control the outward migration of the agent to enable prolonged release of the agent from the surface of the medical device to prevent the adverse reaction due to the presence of the device.
REFERENCES:
patent: 3663288 (1972-05-01), Miller
patent: 3705938 (1972-12-01), Hyman et al.
patent: 3715277 (1973-02-01), Dinelli
patent: 3864468 (1974-02-01), Hyman et al.
patent: 3932656 (1976-01-01), Ramwell et al.
patent: 3959128 (1976-05-01), Harris
patent: 4054139 (1977-10-01), Crossley
patent: 4116898 (1978-09-01), Dudley
patent: 4164560 (1979-08-01), Folkman
patent: 4326532 (1982-04-01), Hammar
patent: 4343788 (1982-08-01), Mustacich
patent: 4353996 (1982-10-01), Marconi
patent: 4357312 (1982-11-01), Hsieh
patent: 4391797 (1983-07-01), Folkman
patent: 4400374 (1983-08-01), Cardarelli
patent: 4479795 (1984-10-01), Mustacich
patent: 4481323 (1984-11-01), Sterling
patent: 4515593 (1985-05-01), Norton
patent: 4557724 (1985-12-01), Gegonis
patent: 4581028 (1986-04-01), Fox, Jr. et al.
patent: 4592920 (1986-06-01), Murtfeldt
patent: 4603152 (1986-07-01), Laurin
patent: 4627850 (1986-12-01), Deters
patent: 4663308 (1987-05-01), Saffran
patent: 4670313 (1987-06-01), Saudagar
patent: 4676975 (1987-06-01), McGary et al.
patent: 4789720 (1988-12-01), Teffenhart
patent: 4810843 (1989-03-01), Gould
patent: 4844986 (1989-07-01), Karekelle
patent: 4861627 (1989-08-01), Mathiowitz
patent: 4874373 (1989-10-01), Luther
patent: 4891225 (1990-01-01), Langer et al.
patent: 4898734 (1990-02-01), Mathiowitz
patent: 4900556 (1990-02-01), Wheatley
patent: 4906474 (1990-03-01), Langer
patent: 4925668 (1990-05-01), Khan et al.
patent: 4946929 (1990-08-01), D'Amore et al.
patent: 4999210 (1991-03-01), Solomon et al.
Brown, "Controlled Release of Insulin from Polymer Matrices In Vitro Kinetics" Diabetes, v. 35, Jun. 1986, p. 684.
Ebert, Medical Applications of Controlled Release, v. 2, chapter 4, p. 77.
Edelmann, "Polymer Matrix Based Controlled Adventitial Delivery of Antiproliferative Agents and Regulation og the Vascular Response to Injury".
Kim, "Heparinized Polymers for Improving Blood Compatability", MD and DI, Aug. 1984, p. 99.
Kim et al., "Heparin Release from Hydrophobic Polymers: (1) In Vitro Studies", Arch. Phar. Research, 9(4) 193-199 (1986).
Lin, "Minimum Heparin Release Rate for Nonthrombogenicity", Trans. Am. Soc. Artif. Intern. Organs vol. XXXIII, 1987, p. 602.
Mcrea, "Prostaglandin Releasing Polymers-Stability and Efficacy", Trans. Am. Soc. Artif. Inter. Organs, vol. XXVII, 1981, p. 511.
Miyama, "A New Antithrombogenic Heparinized Polymer", J. Biomed. Mater. Res., vol. 11, pp. 251-265 (1977).
Noishiki, "Prevention of Thrombosis Related Complications in Cardiac Characterization and Angiography Using a Heparinized Catheter (Anthron.RTM.)", ASAIO, Jul.-Sep. 1987, p. 359.
Polysciencies, Inc., "TDMAC/Heparin Complex Coatings for Preparing Nonthrombogenic Plastic Surfaces", copyright Jul. 1980.
Rhine, "Polymers for Sustained Macromolecular Release: Procedures to Fabricate Reproducible Delivery Systems and Control Release Kinetics", Journal of Pharm. Sciences, vol. 69, No. 3, Mar. 1980.
Ritchel, "Permeability of [.sup.3 H] Water Across A Porous Polymer Matrix Used As A Rate-Limiting Shell in Compression-coated Tablets", J. Controlled Release, 12 (1990) 97-102.
Sparks, "Reduction of Platelet Deposition on Vascular Graphs Using an Antiplatelet Graft Coating Technique", Abstract in Journal of Surgical Research, 33, 367/373 (1982).
Technical note: "Literature Review of the Use of Heparinized Polyurethane Catheters: Comparison to Silicone and Non-Heparinized Catheters".
Wilson, "Heparinized Polymers as Thromboresistant Biomaterials", Polym-Plast. Technol. Eng., 16(2), 119-208 (1981).
Official Gazette, Mar. 6, 1990, p. 393, Pat. No. 4,906,465,
Official Gazette, Mar. 6, 1990, p. 394, Pat. No. 4,906,474.
Helmus Michael N.
Raleigh Carol L.
Tolkoff M. Joshua
Azpuru Carlos
Harbor Medical Devices, Inc.
Page Thurman K.
LandOfFree
Medical device polymer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical device polymer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical device polymer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-471211